Shilpa Medicare jumps on entering Phase I Clinical Trial for its new biological entity

01 Nov 2021 Evaluate

Shilpa Medicare is currently trading at Rs. 606.00, up by 22.55 points or 3.86% from its previous closing of Rs. 583.45 on the BSE.

The scrip opened at Rs. 586.30 and has touched a high and low of Rs. 615.30 and Rs. 586.30 respectively. So far 16364 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 670.95 on 22-Jul-2021 and a 52 week low of Rs. 317.05 on 19-Mar-2021.

Last one week high and low of the scrip stood at Rs. 615.30 and Rs. 562.00 respectively. The current market cap of the company is Rs. 4901.40 crore.

The promoters holding in the company stood at 53.25%, while Institutions and Non-Institutions held 15.18% and 31.57% respectively.

Shilpa Medicare (SML), via its wholly owned subsidiary, Shilpa Biologicals (SBPL), has been permitted to conduct a Phase I human clinical study on its flagship novel product - recombinant Human Albumin (NavAlbumin), by the Central Drugs Standard Control Organisation (CDSCO).

The product, is a synthetically developed product as compared to the current process of drawing the same from blood plasma and is backed by granted global patent. It is designated a 'New Biological Entity' and is amongst the first indigenously developed novel molecules entering clinical studies - a significant milestone for the company and potentially large impact for the nation. The Company continues to strengthen its patent protection around the product to ring fence it from any potential competition.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

287.20 -0.20 (-0.07%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×